189 related articles for article (PubMed ID: 20005901)
41. Potential new mechanisms of placental damage in celiac disease: anti-transglutaminase antibodies impair human endometrial angiogenesis.
Di Simone N; De Spirito M; Di Nicuolo F; Tersigni C; Castellani R; Silano M; Maulucci G; Papi M; Marana R; Scambia G; Gasbarrini A
Biol Reprod; 2013 Oct; 89(4):88. PubMed ID: 23966323
[TBL] [Abstract][Full Text] [Related]
42. Serum and intestinal celiac disease-associated antibodies in children with celiac disease younger than 2 years of age.
Maglio M; Tosco A; Paparo F; Auricchio R; Granata V; Colicchio B; Indolfi V; Miele E; Troncone R
J Pediatr Gastroenterol Nutr; 2010 Jan; 50(1):43-8. PubMed ID: 19934769
[TBL] [Abstract][Full Text] [Related]
43. Role of transglutaminase 2 in celiac disease pathogenesis.
Klöck C; Diraimondo TR; Khosla C
Semin Immunopathol; 2012 Jul; 34(4):513-22. PubMed ID: 22437759
[TBL] [Abstract][Full Text] [Related]
44. Human CD14+ macrophages in intestinal lamina propria exhibit potent antigen-presenting ability.
Kamada N; Hisamatsu T; Honda H; Kobayashi T; Chinen H; Kitazume MT; Takayama T; Okamoto S; Koganei K; Sugita A; Kanai T; Hibi T
J Immunol; 2009 Aug; 183(3):1724-31. PubMed ID: 19592647
[TBL] [Abstract][Full Text] [Related]
45. Molecular characterization of covalent complexes between tissue transglutaminase and gliadin peptides.
Fleckenstein B; Qiao SW; Larsen MR; Jung G; Roepstorff P; Sollid LM
J Biol Chem; 2004 Apr; 279(17):17607-16. PubMed ID: 14747475
[TBL] [Abstract][Full Text] [Related]
46. Transglutaminase and the pathogenesis of coeliac disease.
Stenberg P; Roth EB; Sjöberg K
Eur J Intern Med; 2008 Mar; 19(2):83-91. PubMed ID: 18249302
[TBL] [Abstract][Full Text] [Related]
47. In vivo evaluation of type 2 transglutaminase contribution to the metastasis formation in melanoma.
Di Giacomo G; Lentini A; Beninati S; Piacentini M; Rodolfo C
Amino Acids; 2009 Apr; 36(4):717-24. PubMed ID: 18594948
[TBL] [Abstract][Full Text] [Related]
48. Thioredoxin-1 Selectively Activates Transglutaminase 2 in the Extracellular Matrix of the Small Intestine: IMPLICATIONS FOR CELIAC DISEASE.
Plugis NM; Palanski BA; Weng CH; Albertelli M; Khosla C
J Biol Chem; 2017 Feb; 292(5):2000-2008. PubMed ID: 28003361
[TBL] [Abstract][Full Text] [Related]
49. Transglutaminase 2 cross-linking of matrix proteins: biological significance and medical applications.
Collighan RJ; Griffin M
Amino Acids; 2009 Apr; 36(4):659-70. PubMed ID: 18982407
[TBL] [Abstract][Full Text] [Related]
50. Transglutaminase 2 in the enterocytes is coeliac specific and gluten dependent.
Biagi F; Campanella J; Laforenza U; Gastaldi G; Tritto S; Grazioli M; Villanacci V; Corazza GR
Dig Liver Dis; 2006 Sep; 38(9):652-8. PubMed ID: 16916632
[TBL] [Abstract][Full Text] [Related]
51. Immunoglobulin A anti-tissue transglutaminase antibody deposits in the small intestinal mucosa of children with no villous atrophy.
Tosco A; Maglio M; Paparo F; Rapacciuolo L; Sannino A; Miele E; Barone MV; Auricchio R; Troncone R
J Pediatr Gastroenterol Nutr; 2008 Sep; 47(3):293-8. PubMed ID: 18728524
[TBL] [Abstract][Full Text] [Related]
52. PI3K p110beta positively regulates lipopolysaccharide-induced IL-12 production in human macrophages and dendritic cells and JNK1 plays a novel role.
Utsugi M; Dobashi K; Ono A; Ishizuka T; Matsuzaki S; Hisada T; Shimizu Y; Kawata T; Aoki H; Kamide Y; Mori M
J Immunol; 2009 May; 182(9):5225-31. PubMed ID: 19380768
[TBL] [Abstract][Full Text] [Related]
53. Identification of Isopeptides Between Human Tissue Transglutaminase and Wheat, Rye, and Barley Gluten Peptides.
Lexhaller B; Ludwig C; Scherf KA
Sci Rep; 2020 May; 10(1):7426. PubMed ID: 32367038
[TBL] [Abstract][Full Text] [Related]
54. Features of ZED1227: The First-In-Class Tissue Transglutaminase Inhibitor Undergoing Clinical Evaluation for the Treatment of Celiac Disease.
Büchold C; Hils M; Gerlach U; Weber J; Pelzer C; Heil A; Aeschlimann D; Pasternack R
Cells; 2022 May; 11(10):. PubMed ID: 35626704
[TBL] [Abstract][Full Text] [Related]
55. Interactions of proteoliposomes from serogroup B Neisseria meningitidis with bone marrow-derived dendritic cells and macrophages: adjuvant effects and antigen delivery.
Rodríguez T; Pérez O; Ménager N; Ugrinovic S; Bracho G; Mastroeni P
Vaccine; 2005 Jan; 23(10):1312-21. PubMed ID: 15652674
[TBL] [Abstract][Full Text] [Related]
56. Transglutaminase 2 interactions with extracellular matrix proteins as probed with celiac disease autoantibodies.
Cardoso I; Stamnaes J; Andersen JT; Melino G; Iversen R; Sollid LM
FEBS J; 2015 Jun; 282(11):2063-75. PubMed ID: 25808416
[TBL] [Abstract][Full Text] [Related]
57. Transglutaminase 2 strongly binds to an extracellular matrix component other than fibronectin via its second C-terminal beta-barrel domain.
Stamnaes J; Cardoso I; Iversen R; Sollid LM
FEBS J; 2016 Nov; 283(21):3994-4010. PubMed ID: 27685605
[TBL] [Abstract][Full Text] [Related]
58. Transglutaminase as a therapeutic target for celiac disease.
Sulic AM; Kurppa K; Rauhavirta T; Kaukinen K; Lindfors K
Expert Opin Ther Targets; 2015 Mar; 19(3):335-48. PubMed ID: 25410283
[TBL] [Abstract][Full Text] [Related]
59. Transglutaminase 2 interacts with syndecan-4 and CD44 at the surface of human macrophages to promote removal of apoptotic cells.
Nadella V; Wang Z; Johnson TS; Griffin M; Devitt A
Biochim Biophys Acta; 2015 Jan; 1853(1):201-12. PubMed ID: 25449226
[TBL] [Abstract][Full Text] [Related]
60. Enhanced transglutaminase 2 expression in response to stress-related catecholamines in macrophages.
Yanagawa Y; Hiraide S; Matsumoto M; Shimamura K; Togashi H
Immunobiology; 2014 Sep; 219(9):680-6. PubMed ID: 24863408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
